Myelodysplastic Syndromes
> Centers of Research for Myelodysplastic Syndromes
> Other Countries
> Canada
Previous Section
Other Countries
Canada
| Name of Author | Institutional Affiliation |
|---|---|
| Disperati P | Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, Ont., Canada. |
Next: China
Myelodysplastic Syndromes
- Understanding Myelodysplastic Syndromes
- Introduction to Myelodysplastic Syndromes
- Diagnosis of Myelodysplastic Syndromes
- Treatment Options for Myelodysplastic Syndromes
- Goals of Treatment for Myelodysplastic Syndromes
- Stem Cell Transplantation for Myelodysplastic Syndromes
- Intensive Chemotherapy for Myelodysplastic Syndromes
- Recombinant Human Erythropoietin for Myelodysplastic Syndromes
- Growth Factors in Myelodysplastic Syndromes
- Immunosuppressive Therapy for Myelodysplastic Syndromes
- Supportive Therapy for Myelodysplastic Syndromes
- Treatment for High-Risk Patients with Myelodysplastic Syndromes
- Treatment for Low-Risk Patients with Myelodysplastic Syndromes
- Treatment of Childhood Myelodysplastic Syndromes
- The Role of Complementary and Alternative Therapies in Cancer
- Quality of Life Issues in Cancer
- New Developments in Myelodysplastic Syndromes
- Questions to Ask Your Health Care Provider about Myelodysplastic Syndromes
- What Your Doctor is Reading About Myelodysplastic Syndromes
- Centers of Research for Myelodysplastic Syndromes
- Finding the Best Doctor for You
- Resources and Support Groups for Myelodysplastic Syndromes
Visitor Feedback
"The Medifocus Guidebook is helping me to understand my condition much more in-depth than before. My doctor described the disease in medically technical terms only. I have used my Guidebook to access a variety of information sources and now have not only a better understanding of my ailment, but also several treatments have been revealed which I did not previously know about."
J.H., Nashville, Tennessee
